Sugi Predict

Sugi Predict / Compounds / SCHEMBL972297

SCHEMBL972297

SCHEMBL972297

FC(F)(F)c1ccnc(-c2ccccc2Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 1/20 0.45
▸ EPAS1 Q99814 1/20 0.45
▸ NOS3 P29474 1/20 0.44
▸ NOS2 P35228 1/20 0.44
▸ CBFB Q13951 1/20 0.44
▸ GPBAR1 Q8TDU6 1/20 0.44
▸ RORC P51449 1/20 0.43
▸ RORB Q92753 1/20 0.43
▸ NPC1 O15118 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ GSK3A P49840 1/20 0.41
▸ GSK3B P49841 1/20 0.41
▸ TAS2R14 Q9NYV8 1/20 0.41
▸ P2RX7 Q99572 1/20 0.41
▸ MAPKAPK2 P49137 1/20 0.40
▸ PDE2A O00408 1/20 0.40
▸ PDE10A Q9Y233 1/20 0.40
▸ STK10 O94804 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28726696 0.81 NPC1 (0.49) NOS3NOS2GPBAR1NPC1MAPK1
SCHEMBL29473449 0.81 HSP90AA1 (0.50) HSD11B1CBFBGPBAR1RORCRORB
SCHEMBL322548 0.80 HSD17B10 (0.50) NOS3NOS2MAPK1GSK3AGSK3B
SCHEMBL810884 0.78 NOS3 (0.61) NOS3NOS2CBFBMAPK1CNR2
SCHEMBL5673245 0.77 CCR1 (0.46) NPC1MAPK1RAB9AMAPKAPK2HSP90AA1
SCHEMBL969554 0.77 HSP90AA1 (0.54) HSD11B1CBFBGPBAR1RORCRORB
SCHEMBL901856 0.75 NOS3 (0.51) NOS3NOS2CBFBMAPK1GSK3B
SCHEMBL5331896 0.75 NPC1 (0.53) HSD11B1CBFBNPC1MAPK1RAB9A
SCHEMBL24363083 0.75 KDM4E (0.54) NOS3NOS2CBFBNPC1MAPK1
SCHEMBL2625107 0.75 ASIC3 (0.53) NOS3NOS2NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110156668-B Method for synthesizing 4-polyfluoroalkyl-2, 6-diaryl substituted pyridine compound 福州大学 2022-04-26 — — CN disclosed
US-20140364450-A1 AMINOPYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED 2014-12-11 — — US disclosed
US-20140364450-A1 AMINOPYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED 2014-12-11 — — US disclosed
US-8735593-B2 Aminopyridines useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-05-27 — — US disclosed
US-8735593-B2 Aminopyridines useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-05-27 — — US disclosed
US-20130245273-A1 AMINOPYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-09-19 — — US disclosed
US-20130245273-A1 AMINOPYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-09-19 — — US disclosed
US-8410133-B2 Aminopyridines useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-04-02 — — US disclosed
US-8410133-B2 Aminopyridines useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-04-02 — — US disclosed
US-20110224197-A1 PYRIMIDINES AND PYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-15 — — US disclosed
US-20110224197-A1 PYRIMIDINES AND PYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-15 — — US disclosed
US-20110021559-A1 AMINOPYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-01-27 — — US disclosed
US-20110021559-A1 AMINOPYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-01-27 — — US disclosed
EP-2262498-A2 PYRIMIDINES AND PYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES Vertex Pharmceuticals Incorporated (US) 2010-12-22 — — EP disclosed
WO-2009145814-A9 PYRIMIDINES AND PYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-14 — — WO disclosed
CN-101657447-A Aminopyridines useful as inhibitors of protein kinases VERTEX PHARMA US 2010-02-24 — — CN disclosed
EP-2134709-A1 AMINOPYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES Vertex Pharmaceuticals, Inc. (US) 2009-12-23 — — EP disclosed
WO-2009145814-A2 PYRIMIDINES AND PYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-12-03 — — WO disclosed
WO-2008112646-A1 AMINOPYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-09-18 — — WO disclosed
WO-2008112646-A1 AMINOPYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-09-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130245273-A1 AMINOPYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES MAP4K5, MAP3K5, MAP3K20 HSD11B1 4764/4885EPAS1 1068/4885NOS3 1522/4885
US-20110021559-A1 AMINOPYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES MAP4K5, MAP3K5, MAP3K20 HSD11B1 4764/4885EPAS1 1068/4885NOS3 1522/4885
US-20110224197-A1 PYRIMIDINES AND PYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES GSK3B, CDK3, GSK3A HSD11B1 4400/4885EPAS1 2106/4885NOS3 1050/4885
US-20140364450-A1 AMINOPYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES MAP4K5, MAP3K5, MAP3K20 HSD11B1 4764/4885EPAS1 1068/4885NOS3 1522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.